CER Groupe
CER Groupe is a research center dedicated to supporting human and animal health through high-quality services and innovative products in the biotech, pharma, food safety, and agriculture sectors. Located within the Walloon biotech network, it offers end-to-end pre-clinical solutions in a regulated environment, helping companies to incubate, grow, and succeed in Belgium and abroad. The group emphasizes innovation and excellence, with a focus on research, development, and high-standard manufacturing.
Industries
Nr. of Employees
medium (51-250)
CER Groupe
Rue de la Science, 8 - 6900 MARCHE-EN-FAMENNE
Products
Monoclonal and polyclonal antibodies
Custom-developed and produced monoclonal and polyclonal antibodies for research, diagnostic and therapeutic reagent use, with characterization and engineering services (sequencing, reformatting, conjugation).
Recombinant proteins and isotope-labeled standards
Recombinant antigens, proteins and stable isotope-labeled concatenated standards for quantitative mass spectrometry and diagnostic applications, produced at research and preclinical scales.
Preclinical viral vector batches (AAV, lentivirus)
Preclinical-scale production, purification and characterization of viral vectors (AAV and lentiviral), intended for research and preclinical development and for facilitating later GMP transfer.
Diagnostic kits and reagents
Manufacture and supply of reagents and diagnostic kits for the food and pharma sectors, supported by internal analytical characterization and QA systems.
Polyclonal serum for therapeutic reagent use
Supply of polyclonal serum products used as base reagents in manufacturing of immunosuppressive and other therapeutic processes.
Monoclonal and polyclonal antibodies
Custom-developed and produced monoclonal and polyclonal antibodies for research, diagnostic and therapeutic reagent use, with characterization and engineering services (sequencing, reformatting, conjugation).
Recombinant proteins and isotope-labeled standards
Recombinant antigens, proteins and stable isotope-labeled concatenated standards for quantitative mass spectrometry and diagnostic applications, produced at research and preclinical scales.
Preclinical viral vector batches (AAV, lentivirus)
Preclinical-scale production, purification and characterization of viral vectors (AAV and lentiviral), intended for research and preclinical development and for facilitating later GMP transfer.
Diagnostic kits and reagents
Manufacture and supply of reagents and diagnostic kits for the food and pharma sectors, supported by internal analytical characterization and QA systems.
Polyclonal serum for therapeutic reagent use
Supply of polyclonal serum products used as base reagents in manufacturing of immunosuppressive and other therapeutic processes.
Services
End-to-end services covering antigen design, gene optimization, expression (prokaryotic and mammalian), purification, stabilization and QC for research and preclinical applications.
Custom development of monoclonal and polyclonal antibodies, including host-species selection, hybridoma and rabbit monoclonal methods, antibody engineering (sequencing, reformatting, conjugation) and manufacturing.
Design, small-scale production, purification, scale-up and in-vitro/in-vivo characterization of lentiviral and AAV vectors for research and preclinical development, with processes oriented for GMP tech transfer.
Optimization and modelling of upstream and downstream bioprocesses to improve yield, product quality and cost-efficiency for biologics manufacturing.
Comprehensive physico-chemical and activity testing services including mass spectrometry, chromatography, electrophoresis, binding assays, cell-based assays and in-vivo testing, with tailored validation levels.
Design and conduct of non-clinical in-vivo studies, including GLP studies, across multiple species with facilities supporting SPF through BSL-3 levels and infrastructure for large-animal work.
End-to-end services covering antigen design, gene optimization, expression (prokaryotic and mammalian), purification, stabilization and QC for research and preclinical applications.
Custom development of monoclonal and polyclonal antibodies, including host-species selection, hybridoma and rabbit monoclonal methods, antibody engineering (sequencing, reformatting, conjugation) and manufacturing.
Design, small-scale production, purification, scale-up and in-vitro/in-vivo characterization of lentiviral and AAV vectors for research and preclinical development, with processes oriented for GMP tech transfer.
Optimization and modelling of upstream and downstream bioprocesses to improve yield, product quality and cost-efficiency for biologics manufacturing.
Comprehensive physico-chemical and activity testing services including mass spectrometry, chromatography, electrophoresis, binding assays, cell-based assays and in-vivo testing, with tailored validation levels.
Design and conduct of non-clinical in-vivo studies, including GLP studies, across multiple species with facilities supporting SPF through BSL-3 levels and infrastructure for large-animal work.
Expertise Areas
- Preclinical development and GLP studies
- Bioproduction and process development
- Antibody discovery, engineering and manufacturing
- Viral vector design and preclinical manufacturing
Key Technologies
- Mass spectrometry
- Flow cytometry
- ELISA / CLIA
- Biolayer interferometry